Quetiapin Actavis Filmuhúðuð tafla 100 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

quetiapin actavis filmuhúðuð tafla 100 mg

actavis group ptc ehf. - quetiapinum fúmarat - filmuhúðuð tafla - 100 mg

Vildagliptin/Metformin Krka Filmuhúðuð tafla 50 mg/1000 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

vildagliptin/metformin krka filmuhúðuð tafla 50 mg/1000 mg

krka d.d. novo mesto* - metforminum hýdróklóríð; vildagliptinum inn - filmuhúðuð tafla - 50 mg/1000 mg

Rosuvastatin Xiromed Filmuhúðuð tafla 10 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

rosuvastatin xiromed filmuhúðuð tafla 10 mg

medical valley invest ab - rosuvastatinum kalsíum - filmuhúðuð tafla - 10 mg

Emla (EMLA) Krem 25+25 mg/g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

emla (emla) krem 25+25 mg/g

aspen pharma trading limited - lidocainum inn; prilocainum inn - krem - 25+25 mg/g

Travoprost/Timolol STADA Augndropar, lausn 40 míkróg/ml + 5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

travoprost/timolol stada augndropar, lausn 40 míkróg/ml + 5 mg/ml

stada arzneimittel ag - travoprostinum inn; timololum maleat - augndropar, lausn - 40 míkróg/ml + 5 mg/ml

Travoprost/Timolol Medical Valley Augndropar, lausn 40 míkróg/ml + 5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

travoprost/timolol medical valley augndropar, lausn 40 míkróg/ml + 5 mg/ml

medical valley invest ab - travoprostinum inn; timololum maleat - augndropar, lausn - 40 míkróg/ml + 5 mg/ml

Elzonris Evrópusambandið - íslenska - EMA (European Medicines Agency)

elzonris

stemline therapeutics b.v. - tagraxofusp - lymphoma - Æxlishemjandi lyf - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).

Kimmtrak Evrópusambandið - íslenska - EMA (European Medicines Agency)

kimmtrak

immunocore ireland limited - tebentafusp - uveal neoplasms - Æxlishemjandi lyf - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.